Ayurvedic gastroenterology – Ayurved Healing

Ayurvedic GERD Protocol: Treating Acid Reflux at the Root

Dr. Ananya Sharma — Mon, 23 Feb 2026 01:40:02 +0000

Ayurvedic GERD Protocol: Treating Acid Reflux at the Root

Gastroesophageal reflux disease (GERD) is a chronic reflux condition in which stomach contents move upward into the esophagus and produce troublesome symptoms such as heartburn and regurgitation. Population estimates vary widely by region, and GERD remains one of the most common digestive complaints seen in clinical practice. Ayurveda approaches many reflux-dominant presentations through the framework of Amlapitta, while also recognizing that persistent reflux, chest pain, bleeding, difficulty swallowing, weight loss, or symptoms not improving with care require medical evaluation.

Ayurvedic Understanding: GERD as Amlapitta

Amlapitta literally combines amla (sour) and pitta. Classical Ayurvedic sources, especially the Amlapitta discussions associated with Kashyapa Samhita and Madhava Nidana, describe a pitta-dominant digestive disorder involving sourness, burning, disturbed digestion, nausea, eructation, and upward or downward movement of symptoms. Amlapitta is not a one-to-one synonym for every biomedical case of GERD, but it is the closest Ayurvedic diagnostic framework for reflux patterns marked by sour belching, burning in the chest or throat, acidity, nausea, and pitta-aggravating triggers.

The Two Directions of Amlapitta

Madhava Nidana describes Amlapitta with upward-moving and downward-moving patterns. This distinction matters clinically because reflux-dominant patients often require a different emphasis from patients whose acidity is accompanied mainly by loose stools, lower abdominal burning, or skin manifestations.

Urdhvaga Amlapitta: The upward-moving pattern is the closest classical fit for acid reflux, sour or bitter eructation, nausea, burning in the chest or throat, and regurgitation-like complaints. In a modern integrative setting, this pattern is assessed alongside GERD mechanisms such as reflux of gastric contents, lower esophageal sphincter dysfunction, delayed clearance, hiatal hernia, and meal-timing triggers.
Adhoga Amlapitta: The downward-moving pattern is associated more with burning, thirst, loose stools, abdominal discomfort, sweating, yellowish discoloration, and pitta-type skin eruptions. When reflux symptoms coexist with diarrhea, bleeding, fever, severe abdominal pain, or dehydration, the patient should be referred for appropriate medical assessment.

Samprapti: The Ayurvedic Root-Cause Model

In Ayurvedic pathogenesis, Amlapitta begins with repeated exposure to pitta-aggravating food and conduct: excessive sour, salty, pungent, hot, fried, fermented, incompatible, stale, or irregularly timed food; overeating; eating before the previous meal is digested; late nights; emotional heat; and suppression of natural rhythms. These factors disturb Agni, aggravate Pachaka Pitta, and contribute to sour, irritating, poorly processed digestive contents. The treatment goal is therefore not only to suppress burning, but also to restore meal discipline, calm aggravated pitta, support mucosal comfort, and rebuild steady digestive function.

The Ayurvedic Treatment Protocol for GERD

A practical Ayurvedic protocol for GERD-like Amlapitta combines nidana parivarjana (removal of causes), pitta-pacifying diet, meal timing, sleep correction, stress regulation, and carefully selected herbs or formulations. Mineral preparations and long-term herbs should be used only under a qualified Ayurvedic practitioner or physician, especially when the patient is pregnant, elderly, has kidney or heart disease, has hypertension, or is taking prescription medicines.

Phase 1: Calm Burning and Reduce Reflux Triggers

The first phase focuses on reducing active burning, sour regurgitation, nausea, and night reflux. The foundation is immediate correction of food triggers and meal timing: smaller meals, no lying down after food, early dinner, avoidance of alcohol and smoking, and head-of-bed elevation when symptoms occur at night.

Pravala-based and mukta-based pitta-pacifying preparations: In classical practice, practitioners may use calcium-containing pitta-pacifying mineral preparations such as Pravala Pishti or selected Kamadudha Rasa variants when burning, sourness, and heat signs are prominent. These are not casual home remedies. They should be sourced from licensed manufacturers, checked for quality, and prescribed according to constitution, age, disease strength, bowel pattern, pregnancy status, kidney-stone history, calcium status, and concurrent medication use.

Simple household supports: Fennel infusion, coriander water, small amounts of ghee with suitable food, and bland, warm, freshly cooked meals may be used as supportive measures when tolerated. These supports are not substitutes for medical care in severe GERD, erosive esophagitis, ulcer disease, Barrett’s esophagus, gastrointestinal bleeding, or unexplained chest pain.

Phase 2: Restore Agni Without Overheating Pitta

The second phase addresses the recurrent pattern: unstable digestion, sour belching after meals, heaviness, incomplete digestion, constipation or irregular stool, and dependence on antacids. The aim is to kindle digestion gently without using heating herbs in a way that worsens pitta.

Yashtimadhu (Glycyrrhiza glabra): The Ayurvedic Pharmacopoeia of India identifies Yashti/Yashtimadhu as Glycyrrhiza glabra root and stolon, with madhura rasa, guru-snigdha guna, sheeta virya, madhura vipaka, and vatapittajit action. In Amlapitta practice, it is valued for its sweet, cooling, soothing, and pitta-pacifying profile. Non-deglycyrrhizinated licorice is not suitable for unsupervised long-term use because glycyrrhizin-containing licorice can raise blood pressure, lower potassium, and cause fluid retention in susceptible people.

Shatavari (Asparagus racemosus): The Ayurvedic Pharmacopoeia of India lists Shatavari root as madhura-tikta in rasa, guru-snigdha in guna, sheeta in virya, madhura in vipaka, and pittahara-rasayana in action, with Amlapitta among its therapeutic uses. In reflux-dominant Amlapitta, it is especially appropriate when burning is accompanied by dryness, depletion, low body weight, tissue sensitivity, or a history of repeated irritation.

Avipattikara Churna: Avipattikara Churna is a classical powder formulation listed in the Ayurvedic Pharmacopoeia/Formulary tradition for Amlapitta and digestive impairment. Its formulation includes Trikatu, Triphala, Musta, Vidanga, Ela, Tejapatra, Lavanga, Trivrit, and sugar in specified proportions. It is generally chosen when acidity is accompanied by constipation, heaviness, impaired digestion, or a need for mild downward regulation. Because it contains Trivrit and a large sugar component, it should be individualized in loose stools, pregnancy, frailty, diabetes, dehydration risk, and inflammatory bowel conditions.

Phase 3: Rebuild and Prevent Recurrence

Once active burning is controlled, the protocol shifts toward maintaining a calm pitta state, restoring regular bowel movement, and preventing relapse from late meals, excess spice, alcohol, stress, or overeating. This is the phase where many patients fail if they stop the diet and routine as soon as symptoms reduce.

Amalaki (Phyllanthus emblica / Emblica officinalis): The Ayurvedic Pharmacopoeia of India lists Amalaki as having five tastes except salt, with sheeta virya, madhura vipaka, rasayana action, and Amlapitta among its therapeutic uses. Its sour taste does not make it automatically pitta-aggravating in classical use because its cooling potency and sweet post-digestive effect are central to its pitta-balancing profile. In practice, Amalaki is best introduced when acute sour regurgitation is settling and the patient can tolerate it without irritation.

Protocol at a Glance

The following outline is an educational framework, not a fixed prescription. Duration, dose, formulation choice, and whether to combine with conventional treatment depend on severity, endoscopy findings, age, pregnancy status, bowel pattern, medication history, and red-flag symptoms.

Phase	Main Aim	Common Ayurvedic Supports	Clinical Monitoring
Phase 1	Calm burning, sour regurgitation, and night reflux	Pitta-pacifying diet, early dinner, head elevation, practitioner-selected cooling formulations	Daily symptom frequency, food triggers, sleep symptoms, warning signs
Phase 2	Restore Agni without provoking pitta	Yashtimadhu, Shatavari, Avipattikara Churna when appropriate	Appetite, stool pattern, belching, medication use, blood pressure if licorice is used
Phase 3	Rebuild tolerance and prevent relapse	Amalaki, Shatavari, gentle rasayana support, sustained pathya	Relapse triggers, meal discipline, stress load, need for medical follow-up
Maintenance	Keep pitta and Agni stable seasonally	Seasonal pitta-pacifying food, regular sleep, stress practices, individualized herbs only when needed	Review if symptoms recur, worsen, or require frequent acid-suppressing medicines

Dietary Modifications for Amlapitta

Diet is the backbone of Amlapitta management. Ayurveda emphasizes avoiding the causes of the disease, while modern GERD guidance also supports individual trigger identification, weight management when overweight, avoidance of late meals, and practical nighttime measures.

Foods to Favor

For reflux-dominant Amlapitta, food should be fresh, warm, simple, moderately moist, and easy to digest. The goal is to calm pitta without extinguishing Agni.

Gentle grains: Old rice, basmati rice, wheat preparations when tolerated, oats, and barley.
Cooling vegetables: Bottle gourd, ash gourd, ridge gourd, pumpkin, cucumber when digestion permits, zucchini, asparagus, and mild leafy greens.
Suitable fruits: Ripe sweet pear, sweet pomegranate, ripe banana when tolerated, melon away from meals, and soaked raisins.
Useful fats: Small amounts of ghee with meals when digestion is not heavy or sluggish.
Drinks: Room-temperature water, coriander water, fennel tea, and coconut water when suitable for the patient’s digestion and glucose status.

Foods and Habits to Reduce or Avoid

Avoidance should be practical and individualized, but reflux patients commonly worsen with late dinners, overeating, alcohol, smoking, excess coffee, chocolate, tomato-heavy meals, deep-fried food, and very spicy food. In Ayurveda, the same pattern is understood as pitta-aggravating and Agni-disturbing.

Pitta-provoking foods: Excess chili, sour pickles, vinegar, fermented foods, very salty snacks, sour curd, and heavily spiced preparations.
Common GERD triggers: Coffee, alcohol, chocolate, peppermint, tomato products, greasy foods, carbonated drinks, and large late meals.
Heavy foods: Deep-fried food, heavy cream sauces, processed snacks, and overeating at night.
Viruddha ahara patterns: Milk with sour foods, fruit mixed into heavy meals, reheated stale food, and incompatible combinations that leave heaviness or sour belching.

The Sattvic Framework

A sattvic dietary pattern suits many Amlapitta patients because it favors fresh, simple, lightly cooked, non-irritating, and digestible meals. The practical test is not ideology but response: after eating, the patient should feel light, satisfied, clear, and free from sour eructation, burning, bloating, and sleep disturbance.

Lifestyle Modifications

Lifestyle is not secondary in Amlapitta. Reflux is often maintained by repeated timing errors: large dinners, lying down too soon, working late after heavy food, sleeping flat, and eating under emotional strain.

Eating Habits

Correct eating rhythm reduces both pitta aggravation and mechanical reflux pressure. These habits should be practiced daily before judging whether herbs are working.

Eat the main meal at midday when appetite and digestive capacity are usually strongest.
Keep dinner light and finish it at least 2-3 hours before lying down.
Eat slowly, chew thoroughly, and stop before heaviness appears.
Avoid large volumes of liquid during meals; sip as needed.
Take a gentle walk after dinner instead of lying down or bending forward.
Avoid tight belts or clothing that increases abdominal pressure after meals.

Sleep and Night Reflux

For nocturnal reflux, head-of-bed elevation and left-side sleeping are practical, low-risk measures for many patients. A wedge or bed elevation works better than simply stacking pillows, which may bend the torso and worsen pressure in some people.

Elevate the head end of the bed when symptoms occur at night.
Try left lateral sleep positioning if right-side or flat sleep worsens reflux.
Avoid late snacks, late tea or coffee, alcohol, and heavy dinners.
Seek medical advice if nighttime reflux causes choking, cough, hoarseness, wheezing, or disturbed breathing.

Stress Regulation

Stress can worsen reflux symptoms and symptom sensitivity. Ayurveda treats this as part of pitta regulation: the mind, sleep rhythm, breath, and digestion are managed together rather than separately.

Cooling pranayama: Sheetali or Sheetkari may be used when suitable, avoiding them in cold weather sensitivity, respiratory discomfort, or when they cause unease.
Diaphragmatic breathing: Slow abdominal breathing may support the anti-reflux barrier and reduce symptom perception in selected patients.
Yoga Nidra and meditation: These are useful when reflux flares during worry, overwork, anger, or poor sleep.
Abhyanga: Gentle oil massage with a constitution-appropriate oil may support sleep and nervous-system settling; avoid heavy oiling immediately after meals.

Modern Evidence Notes on Key Herbs and Measures

Ayurvedic selection should remain based on the patient’s dosha pattern, Agni, bowel habit, strength, and safety profile. Modern evidence is supportive for some ingredients and lifestyle measures, but it does not replace individualized diagnosis or necessary conventional care.

Yashtimadhu and DGL: Deglycyrrhizinated licorice preparations have been studied for gastric ulcer healing and mucosal support. This supports the traditional selection of Yashtimadhu for soothing pitta-type digestive irritation, while also reinforcing the need to avoid unsupervised long-term glycyrrhizin-containing licorice in patients at risk of hypertension, hypokalemia, edema, kidney disease, or heart disease.

Shatavari: Experimental work on Asparagus racemosus has found anti-ulcer and acid-modulating activity in gastric ulcer models, which is consistent with its classical cooling, nourishing, pitta-pacifying profile.

Amalaki: A randomized placebo-controlled trial of Phyllanthus emblica in non-erosive reflux disease reported improvement in heartburn and regurgitation frequency, supporting its careful use in suitable reflux patients.

Breathing and sleep position: Diaphragmatic breathing has potential benefit in selected GERD patients, and left lateral sleep positioning is associated with reduced nocturnal reflux in modern sleep-position studies. These measures fit well with an Ayurvedic plan because they change the daily pattern that keeps reflux active.

When to Combine with Conventional Treatment

Ayurvedic care and conventional GERD care can be combined responsibly. Patients with frequent symptoms, erosive esophagitis, Barrett’s esophagus, ulcers, strictures, severe regurgitation, chronic cough, asthma-like symptoms, or persistent symptoms despite self-care should be assessed by a physician or gastroenterologist.

During PPI use: Diet, meal timing, head elevation, stress regulation, and gentle Ayurvedic supports may be used alongside prescribed medicines when checked for interactions.
When tapering PPIs: Do not stop long-term PPIs abruptly without prescriber guidance. Rebound acid hypersecretion can occur after withdrawal, and step-down plans should be individualized.
Refractory symptoms: Persistent symptoms despite acid suppression may require evaluation for non-acid reflux, functional heartburn, reflux hypersensitivity, hiatal hernia, medication triggers, delayed gastric emptying, or cardiac causes of chest pain.

Contraindications and Safety Considerations

Natural does not automatically mean safe. Amlapitta patients often self-medicate for months, but reflux-like symptoms can overlap with ulcer disease, gallbladder disease, heart disease, medication injury, infection, malignancy, and pregnancy-related conditions.

Yashtimadhu/licorice: Avoid unsupervised long-term glycyrrhizin-containing licorice in hypertension, kidney disease, heart failure, edema, low potassium, pregnancy, or use of diuretics, digoxin, corticosteroids, antiarrhythmics, or blood-pressure medication unless supervised.
Pravala, mukta, shankha, and other mineral preparations: Use only practitioner-prescribed, quality-tested products. Avoid casual use in hypercalcemia, significant kidney disease, recurrent kidney stones, or when the product quality is uncertain.
Avipattikara Churna: Use cautiously in loose stools, dehydration, frailty, pregnancy, diabetes, and patients sensitive to purgative herbs.
Pregnancy and lactation: Dietary correction may be appropriate, but herbs and mineral formulations require individualized prenatal or postnatal guidance.
Children and older adults: Dose, formulation, and referral threshold should be more conservative.

Red Flags Requiring Immediate Medical Attention

Ayurvedic treatment should never delay medical evaluation when warning symptoms are present. Seek urgent care for chest pain that may be cardiac, difficulty swallowing, painful swallowing, food sticking in the chest, vomiting blood, black or tarry stools, persistent vomiting, choking, unexplained weight loss, anemia, severe abdominal pain, or reflux symptoms that remain frequent despite appropriate care.

Amlapitta care begins with disciplined food and conduct: remove what provokes sour, burning pitta; restore calm digestion; and support the tissues without ignoring medical warning signs.

The Ayurvedic approach to GERD-like Amlapitta is strongest when it remains both classical and practical: pitta-pacifying food, early and lighter dinners, careful herb selection, stress regulation, sleep-position correction, and medical evaluation when symptoms are severe, persistent, atypical, or alarming. Used this way, Ayurveda offers a root-cause digestive framework without replacing the role of modern diagnosis and emergency care.

This article is for educational purposes only and does not diagnose, treat, or replace personalized medical advice. Consult a qualified Ayurvedic practitioner and a licensed healthcare provider before starting herbs, mineral preparations, detoxes, supplements, or therapeutic protocols, especially if pregnant, managing a medical condition, or taking medication.

References

Triphala for IBS: What Gastroenterology Research Actually Shows

Dr. Meera Iyer — Sat, 21 Feb 2026 16:45:11 +0000

Triphala for IBS: Separating Traditional Use from Clinical Evidence

Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction characterized by recurrent abdominal pain associated with altered stool frequency, stool form, or both. It may present as IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), or a mixed pattern (IBS-M). Triphala is widely used in Ayurveda for digestive and bowel complaints, but its suitability cannot be inferred from the label “IBS” alone. Constipation, loose stools, urgency, pain, bloating, appetite, strength, and the possibility of another gastrointestinal disorder must all be considered before an Ayurvedic formulation is selected.

What Triphala Actually Contains

Triphala Churna is traditionally prepared from equal parts of the dried fruit pericarps of Haritaki (Terminalia chebula), Bibhitaka (Terminalia bellirica), and Amalaki (Emblica officinalis, also accepted botanically as Phyllanthus emblica). A traditional powder, a concentrated aqueous extract, and a tablet standardized to selected compounds are not dose-equivalent and may produce different pharmacological exposure.

The Ayurvedic Pharmacopoeia of India identifies tannins, anthraquinones, and polyphenolic compounds in Haritaki; gallic acid, tannic acid, and glycosides in Bibhitaka; and ascorbic acid with gallotannins in dried Amalaki. These monographs support describing Triphala as a tannin- and polyphenol-containing formulation, but they do not justify assigning one fixed vitamin C value to every commercial product. Fruit quality, processing, storage, and formulation type can alter the final chemical profile.

Ingredient	Rasa	Guna	Virya	Vipaka	Selected API actions
Haritaki	Madhura, amla, katu, tikta, kashaya	Laghu, ruksha	Ushna	Madhura	Dipana, anulomana, rasayana, sarvadosha-prashamana
Bibhitaka	Kashaya	Laghu, ruksha	Ushna	Madhura	Kaphapittajit, bhedaka, kriminashana, kasahara
Amalaki	Madhura, amla, katu, tikta, kashaya	Laghu, ruksha	Shita	Madhura	Rasayana, tridoshajit, chakshushya, vrishya

The Ayurvedic Interpretation

Ayurveda does not treat every irregular bowel pattern with the same medicine. Assessment considers agni or digestive capacity, the presence of ama, dosha predominance, stool character, appetite, pain, strength, diet, and season. Haritaki is described as anulomana and dipana, while Bibhitaka is described as bhedaka; these actions make an indiscriminate high-dose approach especially unsuitable when diarrhea, dehydration, marked weakness, or frequent urgency is present.

Grahani is an Ayurvedic disease category centered on impaired digestion and abnormal retention or passage of stool. It overlaps with some symptoms seen in IBS, but it is not an exact synonym for IBS and should not be used as a one-to-one biomedical diagnosis. Classical management is individualized and may include diet, daily routine, digestive measures, bowel-regulating herbs, and treatment directed at the dominant dosha and the patient’s strength.

Microbiome Findings

Laboratory studies using human fecal cultures found that Triphala altered microbial communities, increased several Bifidobacterium, Lactobacillus, and Bacteroides taxa, reduced selected potentially pathogenic organisms, and increased the abundance of some butyrate-producing bacteria. A separate preclinical investigation used in-vitro culture, fruit-fly experiments, and a simulated human gastrointestinal model and also reported growth-promoting effects on selected beneficial organisms.

These experiments help identify possible mechanisms, but they do not establish symptom relief in people with IBS. The available microbiome studies were laboratory or simulated-gut models rather than controlled patient dosing trials. They therefore cannot support a standard claim that a fixed daily dose of Triphala increases human short-chain fatty-acid production or corrects dysbiosis within a specified number of days.

Human Evidence Specifically for IBS

Published human data directly evaluating Triphala for IBS are sparse and do not establish efficacy for IBS-C, IBS-D, or IBS-M. A 2018 clinical review of Triphala and gastrointestinal disorders stated that clinical trials assessing Triphala formulations in IBS were not available at that time. Later Ayurvedic studies in IBS have evaluated broader dietary programs or whole-system treatment rather than isolating Triphala as the tested intervention.

Accordingly, no fixed Triphala dose, expected percentage reduction in IBS severity, or predicted change in weekly bowel frequency can be presented as an established IBS outcome. Evidence from constipation, oral-health, metabolic, or laboratory studies cannot be transferred directly to IBS because the condition includes pain, visceral sensitivity, stool-pattern variability, and gut-brain factors that require diagnosis-specific evaluation.

Dose and Form Require Individual Assessment

The Ayurvedic Pharmacopoeia gives a powdered-fruit dose of 3–6 g for each individual fruit monograph, but this is not an IBS-specific Triphala prescription. Commercial tablets and extracts may be substantially more concentrated than churna, and labels may not clearly indicate an extract ratio. A dose suitable for occasional constipation may aggravate loose stools, cramping, or urgency in another person.

For this reason, rigid protocols such as 3–5 g nightly for every person with IBS-C, a smaller universal dose for IBS-D, or automatic addition of Kutaja or Bilva are not justified without individual examination. Kutaja and Bilva are distinct medicines with their own indications, contraindications, dose ranges, and formulation requirements. Persistent diarrhea should first be assessed for infection, inflammatory bowel disease, celiac disease, medication effects, malabsorption, and other causes rather than being managed by self-prescribed combinations.

Safety, Interactions, and Product Quality

A small phase-I study gave a standardized aqueous Triphala extract at 2,500 mg daily for four weeks to 20 healthy adults and reported no serious adverse effects. This provides limited short-term information for that particular extract; it does not establish long-term safety, safety during pregnancy or breastfeeding, or safety for people with active gastrointestinal disease.

Triphala can produce loose stools, abdominal discomfort, or increased bowel activity, especially when the dose is excessive for the individual. In-vitro studies also show inhibition of several cytochrome P450 enzymes, including CYP3A4, CYP2C9, CYP1A2, and CYP2D6. The clinical importance is uncertain, but people taking prescription medicines—particularly medicines with a narrow therapeutic range—should have the combination reviewed by a pharmacist or qualified clinician.

Product quality matters. Ayurvedic products should come from a manufacturer that provides identity testing, contaminant testing, and batch information. Public-health guidance notes that some Ayurvedic preparations have contained harmful levels of lead, mercury, or arsenic. Although Triphala itself is a plant-based formula, poor manufacturing, adulteration, or contamination can still create avoidable risk.

How Triphala Fits into Evidence-Based IBS Care

Current gastroenterology guidance supports a positive diagnosis of IBS after appropriate evaluation and recommends treatment according to the predominant bowel pattern. Depending on the presentation, care may include soluble fiber, a limited trial of a low-FODMAP diet guided by a trained professional, gut-directed psychotherapy, and prescription therapies selected for IBS-C or IBS-D. Triphala should not replace indicated testing or proven treatment.

Urgent or specialist assessment is especially important when symptoms include rectal bleeding, iron-deficiency anemia, fever, progressive unintentional weight loss, persistent nocturnal diarrhea, a new bowel change later in life, or a family history of colorectal cancer, inflammatory bowel disease, or celiac disease. These features are not typical reasons to begin an unsupervised herbal trial.

Clinical Bottom Line

Triphala is an authentic Ayurvedic formulation with well-defined ingredients and documented traditional properties. Its polyphenols and tannins have plausible gastrointestinal and microbiome-related actions, and a small healthy-volunteer study offers limited short-term safety information for one standardized extract. These findings do not establish Triphala as an effective treatment for IBS or support universal dosing by IBS subtype.

In Ayurvedic practice, Triphala may be considered only after evaluating bowel pattern, digestive strength, dosha features, diet, concurrent illness, and medication use. A supervised, individualized trial may be reasonable for selected adults, particularly when constipation is present, but it should be stopped if diarrhea, pain, dehydration, or other symptoms worsen. Diagnosis and ongoing care should remain coordinated with a qualified Ayurvedic practitioner and a healthcare professional familiar with gastrointestinal disease.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. IBS requires appropriate clinical evaluation. Do not self-prescribe Triphala or combine it with other herbs or prescription medicines without consulting a qualified Ayurvedic practitioner and healthcare provider, especially during pregnancy or breastfeeding or when chronic illness is present.

References

Nothing in this article diagnoses or treats a medical condition. Use it as educational information and consult a qualified Ayurvedic practitioner or physician before starting herbs, supplements, detoxes, or therapeutic protocols, especially if pregnant, managing a condition, or taking medication.